Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist

Volume: 10 Number: 4 December 1, 2013
  • Murat Acar
  • Servet Tatlı
  • Stuart G Silverman
EN TR

Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist

Abstract

Leiomyomatosis peritonealis disseminata (LPD) is a rare disorder characterized by multiple subperitoneal benign smooth muscle nodules. It is usually incidentally discovered during cesarean section or laparoscopy. In this paper, we present pre-and-post GnRH treatment MRI findings of a symptomatic patient with LPD.

Keywords

References

  1. Sharma P, Chaturvedi KU, Gupta R, Nigam S. Leiomyomatosis peritonealis disseminata with malig- nant change in a post-menopausal woman. Gynecol Oncol 2004;95: 742-5.
  2. Halama N, Grauling-Halama SA, Daboul I. Familial cluster- ing of Leiomyomatosis peritonealis disseminata: an un- known genetic syndrome? BMC Gastroenterol 2005;33: 1-5.
  3. Nappi C, Di Spiezio Sardo A, Mandato VD, et al. Leiomyomatosis peritonealis disseminata in association with Currarino syndrome? BMC Cancer 2006; 6:127. 235
  4. Papadatos D, Taourel P, Bret PM. CT of leiomyomatosis peritonealis disseminata mimicking peritoneal carcino- matosis. AJR Am J Roentgenol 1996;167: 475-6.
  5. Kokcu A, Alvur Y, Baris YS, Kuskonmaz I. Leiomyomatosis peritonealis disseminata. Acta Obstet Gynecol Scand 1994;73: 81-3.
  6. Ueda H, Togashi K, Konishi I, et al. Unusual appearances of uterine leiomyomas: MR imaging findings and their his- topathologic backgrounds. Radiographics 19: 1999;131-45.

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Murat Acar This is me

Servet Tatlı This is me

Stuart G Silverman This is me

Publication Date

December 1, 2013

Submission Date

April 27, 2015

Acceptance Date

-

Published in Issue

Year 2013 Volume: 10 Number: 4

APA
Acar, M., Tatlı, S., & Silverman, S. G. (2013). Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist. European Journal of General Medicine, 10(4). https://izlik.org/JA67YR43ER
AMA
1.Acar M, Tatlı S, Silverman SG. Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist. European Journal of General Medicine. 2013;10(4). https://izlik.org/JA67YR43ER
Chicago
Acar, Murat, Servet Tatlı, and Stuart G Silverman. 2013. “Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment With GnRH Agonist”. European Journal of General Medicine 10 (4). https://izlik.org/JA67YR43ER.
EndNote
Acar M, Tatlı S, Silverman SG (December 1, 2013) Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist. European Journal of General Medicine 10 4
IEEE
[1]M. Acar, S. Tatlı, and S. G. Silverman, “Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist”, European Journal of General Medicine, vol. 10, no. 4, Dec. 2013, [Online]. Available: https://izlik.org/JA67YR43ER
ISNAD
Acar, Murat - Tatlı, Servet - Silverman, Stuart G. “Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment With GnRH Agonist”. European Journal of General Medicine 10/4 (December 1, 2013). https://izlik.org/JA67YR43ER.
JAMA
1.Acar M, Tatlı S, Silverman SG. Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist. European Journal of General Medicine. 2013;10. Available at https://izlik.org/JA67YR43ER.
MLA
Acar, Murat, et al. “Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment With GnRH Agonist”. European Journal of General Medicine, vol. 10, no. 4, Dec. 2013, https://izlik.org/JA67YR43ER.
Vancouver
1.Murat Acar, Servet Tatlı, Stuart G Silverman. Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist. European Journal of General Medicine [Internet]. 2013 Dec. 1;10(4). Available from: https://izlik.org/JA67YR43ER